98 related articles for article (PubMed ID: 27539042)
1. [Excretion Management During Colorectal Cancer Chemotherapy].
Koyama T; Kagawa Y; Shimokawa F; Funakoshi S; Nanbara M; Naito A; Hirooka T; Tachihara A; Watanabe M; Kano S; Takeda Y; Tamura S; Kato T; Ikeue H
Gan To Kagaku Ryoho; 2016 Aug; 43(8):989-93. PubMed ID: 27539042
[TBL] [Abstract][Full Text] [Related]
2. Colonic methane production modifies gastrointestinal toxicity associated with adjuvant 5-fluorouracil chemotherapy for colorectal cancer.
Holma R; Korpela R; Sairanen U; Blom M; Rautio M; Poussa T; Saxelin M; Osterlund P
J Clin Gastroenterol; 2013 Jan; 47(1):45-51. PubMed ID: 23090038
[TBL] [Abstract][Full Text] [Related]
3. [Preparation of a brochure for patients undergoing FOLFIRI chemotherapy based on survey of adverse reactions].
Kamisugi K; Matsusaka S; Imada H; Shoji D; Nakamoto E; Yokokawa T; Kawakami K; Hirata Y; Nawano K; Ogawa M; Shinozaki E; Suenaga M; Mizunuma N; Hatake K; Hama T
Gan To Kagaku Ryoho; 2008 Aug; 35(8):1331-5. PubMed ID: 18701844
[TBL] [Abstract][Full Text] [Related]
4. Impact of chemotherapy on gastrointestinal functions and the enteric nervous system.
Escalante J; McQuade RM; Stojanovska V; Nurgali K
Maturitas; 2017 Nov; 105():23-29. PubMed ID: 28545907
[TBL] [Abstract][Full Text] [Related]
5. Nursing intervention to enhance outpatient chemotherapy symptom management: Patient-reported outcomes of a randomized controlled trial.
Traeger L; McDonnell TM; McCarty CE; Greer JA; El-Jawahri A; Temel JS
Cancer; 2015 Nov; 121(21):3905-13. PubMed ID: 26194461
[TBL] [Abstract][Full Text] [Related]
6. [Questionnaire survey on patients receiving scheduled inpatient chemotherapy clarifies the issues of outpatient chemotherapy for advanced or recurrent colorectal cancer].
Arakawa Y; Sakuyama T; Ichiba T; Inoue D; Kobayashi T; Aiba K
Gan To Kagaku Ryoho; 2007 Dec; 34 Suppl 2():245-7. PubMed ID: 20443276
[TBL] [Abstract][Full Text] [Related]
7. Advanced colorectal cancer: current treatment and nursing management with economic considerations.
Viale PH; Fung A; Zitella L
Clin J Oncol Nurs; 2005 Oct; 9(5):541-52. PubMed ID: 16235581
[TBL] [Abstract][Full Text] [Related]
8. Effect of Diversion Ileostomy on the Occurrence and Consequences of Chemotherapy-Induced Diarrhea.
Robertson JP; Wells CI; Vather R; Bissett IP
Dis Colon Rectum; 2016 Mar; 59(3):194-200. PubMed ID: 26855393
[TBL] [Abstract][Full Text] [Related]
9. Risk and outcomes of chemotherapy-induced diarrhea (CID) among patients with colorectal cancer receiving multi-cycle chemotherapy.
Keefe DM; Elting LS; Nguyen HT; Grunberg SM; Aprile G; Bonaventura A; Selva-Nayagam S; Barsevick A; Koczwara B; Sonis ST
Cancer Chemother Pharmacol; 2014 Oct; 74(4):675-80. PubMed ID: 25055935
[TBL] [Abstract][Full Text] [Related]
10. [Multicentral Questionnaire Results for Consciousness of Medical Personnel on Chemotherapy for Gastric and Colorectal Cancer].
Sasaki S; Hiraiwa T; Ishimaru M; Funahashi K; Koike J; Seto Y; Yamashita H; Furushima K; Sakai K
Gan To Kagaku Ryoho; 2018 Aug; 45(8):1171-1176. PubMed ID: 30158413
[TBL] [Abstract][Full Text] [Related]
11. Management of chemotherapy-induced diarrhea and constipation.
Cope DG
Nurs Clin North Am; 2001 Dec; 36(4):695-707, vi. PubMed ID: 11726348
[TBL] [Abstract][Full Text] [Related]
12. Phase I/IIA randomized study of PHY906, a novel herbal agent, as a modulator of chemotherapy in patients with advanced colorectal cancer.
Farrell MP; Kummar S
Clin Colorectal Cancer; 2003 Feb; 2(4):253-6. PubMed ID: 12620148
[No Abstract] [Full Text] [Related]
13. Assessment of a dietary questionnaire in cancer patients receiving cytotoxic chemotherapy.
Meyerhardt JA; Heseltine D; Campos H; Holmes MD; Willett WC; Winer EP; Enzinger PC; Bunnell CA; Kulke MH; Fuchs CS
J Clin Oncol; 2005 Nov; 23(33):8453-60. PubMed ID: 16293876
[TBL] [Abstract][Full Text] [Related]
14. [Team-based medical care can improve tailor made chemotherapy for colorectal cancer].
Muneoka K; Shirai Y; Sasaki M; Kanda J; Asakura T; Wakabayashi H; Toshima M; Hatakeyama K
Gan To Kagaku Ryoho; 2008 Nov; 35(11):1883-7. PubMed ID: 19011336
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the addition of video-based education for patients receiving standard pre-chemotherapy education.
Kinnane N; Thompson L
Eur J Cancer Care (Engl); 2008 Jul; 17(4):328-39. PubMed ID: 18652000
[TBL] [Abstract][Full Text] [Related]
16. Molecular markers of chemotherapeutic response and toxicity in colorectal cancer.
Braun MS; Quirke P; Seymour MT
Expert Rev Anticancer Ther; 2007 Apr; 7(4):489-501. PubMed ID: 17428170
[TBL] [Abstract][Full Text] [Related]
17. Predictive factors for chemotherapy-related toxic effects in patients with colorectal cancer.
Vincenzi B; Schiavon G; Pantano F; Santini D; Tonini G
Nat Clin Pract Oncol; 2008 Aug; 5(8):455-65. PubMed ID: 18542119
[TBL] [Abstract][Full Text] [Related]
18. Managing toxicities associated with antiangiogenic biologic agents in combination with chemotherapy for metastatic colorectal cancer.
Grenon NN
Clin J Oncol Nurs; 2013 Aug; 17(4):425-33. PubMed ID: 23899982
[TBL] [Abstract][Full Text] [Related]
19. [Evaluating the effectiveness and timing of modification of anti-cancer drug therapies for colorectal cancer].
Miyamoto Y; Sakamoto Y; Ozaki N; Ishimoto T; Iwatsuki M; Baba Y; Iwagami S; Yoshida N; Watanabe M; Baba H
Gan To Kagaku Ryoho; 2012 Sep; 39(9):1326-9. PubMed ID: 22996767
[TBL] [Abstract][Full Text] [Related]
20. [The nutritional status of patients with colorectal cancer undergoing chemotherapy].
Heredia M; Canales S; Sáez C; Testillano M
Farm Hosp; 2008; 32(1):35-7. PubMed ID: 18426700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
